Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 21, 2020

Study Completion Date

September 10, 2021

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

HEPA Air Cleaner

Air cleaners containing HEPA and carbon filters (Austin HealthMate HM400) and capable of removing PM and NO2 will be placed in the bedroom and room where the participant reports spending the most time.

DEVICE

Sham HEPA Air Cleaner

Homes in the control group will receive sham air cleaners that have the internal HEPA and carbon filters removed, but which will run normally, including similar noise, airflow and overall appearance compared to active air cleaners, thus blinding participants to filter status.

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

lead

Johns Hopkins University

OTHER

NCT02236858 - Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health | Biotech Hunter | Biotech Hunter